You are here: Industry Insights > COVID-19

News List

UK leads Europe in Phase I and Phase II trials, ABPI findings show europeanpharmaceuticalreview
October 14, 2020
The ABPI has found that the UK is leading the rest of Europe in early-stage clinical trials and makes suggestions on how the country can maintain this position.
Total deaths recorded during the pandemic far exceed those attributed to COVID-19 worldpharmanews
October 14, 2020
For every two deaths attributed to COVID-19 in the U.S., a third American dies as a result of the pandemic, according to new data publishing Oct. 12 in the Journal of the American Medical Association.
World Thrombosis Day Campaign Shines Spotlight on the Life-Threatening Connection Between Thrombosis and COVID-19 prnasia
October 14, 2020
On October 13, the World Thrombosis Day global campaign shares an important message to "Open Your Eyes to Thrombosis and COVID-19."
US, AstraZeneca sign pact for COVID-19 antibody treatment used to treat Trump expresspharma
October 12, 2020
The agreement, under Operation Warp Speed, is to develop a monoclonal antibody cocktail that can prevent COVID-19, especially in high-risk population.
NoveCite to develop stem cell therapies for COVID-19 related respiratory distress europeanpharmaceuticalreview
October 10, 2020
NoveCite has an exclusive licence to develop and commercialise mesenchymal stem cell therapies to treat acute respiratory conditions such as Acute Respiratory Distress Syndrome (ARDS).
Trial testing anti-coronavirus hIVIG plus remdesivir in COVID-19 patients europeanpharmaceuticalreview
October 10, 2020
The ITAC trial will establish if adding hyperimmune intravenous immunoglobulin (hIVIG) to a remdesivir regimen can improve hospitalised COVID-19 patient outcomes.
ARCA gets FDA approval of IND for Covid-19 drug candidate AB201 pharmaceutical-business-review
October 10, 2020
ARCA biopharma said that its investigational new drug (IND) application for AB201 (rNAPc2) as a potential treatment for patients hospitalised with Covid-19 has been approved by the US Food and Drug Administration (FDA).
UK inks deal with Abingdon Health for rapid COVID-19 antibody tests pharmatimes
October 10, 2020
The UK government has announced a deal with Abingdon Health for the supply of the company’s AbC-19 rapid COVID-19 antibody tests.
Charities unite to highlight pandemic’s disruption to cancer services pharmatimes
October 10, 2020
Twenty charities representing people affected by rare and less common cancers have come together to respond to and highlight the disruption caused by the COVID-19 pandemic.
London universities join forces to ramp up COVID-19 testing pharmatimes
October 10, 2020
Leading life sciences universities in London have come together to respond to the current COVID-19 pandemic with the launch of the ‘Testing Alliance’ to offer 20,500 extra tests a day.